SHANGHAI, SHANGHAI, CHINA, April 30, 2026 /EINPresswire.com/ -- In today’s life sciences industry, moving a drug ...

The FDA rejected the promising skin cancer drug RP1 twice, leaving many puzzled and worried about what this means for other ...

Meet the Delawareans making change happen in 2026 in industry and development, part of our Most Influential & Inspiring ...

When we treat cancer patients, their disease can overcome treatment through its innate capacity to adapt. This is at the ...

Virtual control groups, automation, novel excipients, and sustainability are some of the topics covered by PharmTech this ...

U.S. academic medical centers risk losing leadership in drug discovery and development as global competition—especially from ...

Kinases represent one of the largest superfamilies of drug targets, but many members have remained notoriously challenging to drug by traditional small-molecule approaches. This Review assesses ...

Organoids and engineered systems are transforming malaria research, improving drug discovery and understanding of Plasmodium ...

Rare disease research operates under conditions of extreme complexity. These pressures are driving new approaches to evidence ...

SHANGHAI, SHANGHAI, CHINA, April 30, 2026 /EINPresswire.com/ -- The development of new medicines increasingly depends ...

India is expanding to 1,000 accredited clinical trial sites, signaling its ambition to become a global hub for drug ...

A leading Mass. biotech company opened a much anticipated lab and processing space. Here's what it looks like.